MetaVia, Inc. (MTVA) Company Future Sales Volume
The future trading volume of MetaVia Inc (MTVA) on the GURU.Markets daily chart shows volatility, where the 0.00 level serves as a critical mark. This price action reflects the colossal profit potential from a single successful molecule, though it is constrained by capital shortages and regulatory uncertainty. Nevertheless, MetaVia Inc remains a promising brand developing breakthrough therapies for neurodegenerative pathologies.
Metric breakdowns and analytics for MetaVia, Inc. (MTVA)
- stock quotes and analyst forecast:
- market capitalization details:
- issuer book value statistics:
- debt burden and liquidity indicators:
- earnings and market ratios statistics:
MTVA - Net Profit|Expected Profit MetaVia Inc|MTVA - Price to Earnings Multiple|Forward P/E Multiple MetaVia Inc|MTVA - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio MetaVia, Inc.|MTVA - Operating profit EBITDA|Earnings per share for the last twelve months MetaVia|MTVA - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months metaviatx.com|MTVA - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year MetaVia Inc
- revenue and sales proceeds data:
Fundamental company analysis:MetaVia MTVA
Investors struggle to balance an asset's current yield against the risks of buying at a volatility peak. Analyzing the organization's projected sales volume allows for an assessment of demand stability during external shocks via daily price action. This metric measures the fundamental resilience of revenue to exogenous factors. For MetaVia Inc (MTVA), this confirms the commercial potential of secure therapeutic platforms. However, a large-scale crisis could negate the historical stability of this indicator.
Key competitors
Projected Sales Volume BIIB|Projected Sales Volume neurocrine.com (NBIX)|Regencell Bioscience Holdings Limited - Company Future Sales Volume|Company Future Revenue AXSM|ACADIA Pharmaceuticals Inc - Projected Sales Volume|Company Future Sales Xenon Corp XENE|Viking Therapeutics (VKTX) - Company Projected Revenue|Company Revenue Forecast SUPN|CPRX (Catalyst Pharmaceuticals, Inc.) - Projected Sales Volume|Company Future Sales Volume Denali (DNLI)|Company Projected Revenue Harmony Pharma (HRMY)|Company Future Sales Volume Biohaven Corp BHVN|Amylyx Pharmaceuticals - Company Future Sales Volume|Company Projected Revenue Volume TRVI (trevitherapeutics.com)|PRAX: Company Future Sales Volume|AVXL: Company Projected Revenue|CBLL: Projected Sales Volume|Prothena Corp (PRTA) - Projected Sales Volume|Company Projected Revenue Alector Inc.|Company Revenue Forecast ANNX (annexonbio.com)|Projected Sales Volume OMER|NGNE - Company Expected Sales Volume|AC Immune Corp - Company Future Sales Volume|Projected Sales Volume Voyager Corp VYGR|NMRA - Company Projected Revenue|Company Future Revenue SCLX (scilexholding.com)|Tevogen Bio (TVGN) - Company Projected Revenue|Company Expected Sales Volume Alpha Cognition Inc. (ACOG)|Company Projected Revenue Cognition Therapeutics, Inc.|Company Future Sales Volume Inhibikase Pharma (IKT)|Projected Sales Volume SAVA|ASRT - Company Expected Sales Volume|Coya Therapeutics - Company Future Sales Volume|Company Projected Revenue Volume VTGN (VistaGen Therapeutics, Inc.)|Ovid Rx - Projected Sales Volume|ABOS - Projected Sales Volume|CRVO (CervoMed Inc.) - Company Future Sales Volume|ATHE (Alterity Therapeutics Limited) - Company Projected Revenue|CLNN (Clene Inc) - Projected Sales Volume|PepGen Corp (PEPG) - Company Future Sales|Projected Sales Volume JUNS|Projected Sales Volume Relmada Corp (RLMD)|Annovis Bio, Inc. - Company Future Sales Volume|Company Future Revenue GRCE|Firefly Neuroscience - Projected Sales Volume|Company Future Sales Klotho Neurosciences Inc KLTO|neurosense-tx.com (NRSN) - Company Projected Revenue|Company Revenue Forecast RVPH|NRXS (NeurAxis, Inc.) - Projected Sales Volume|Company Future Sales Volume Helius Medical Technologies Inc. (HSDT)|Company Projected Revenue Passage Bio, Inc. (PASG)|Company Future Sales Volume bionomics.com.au NEUP|Minerva Neurosciences Corp - Company Future Sales Volume|Company Projected Revenue Volume ATHA (Athira Pharma Corp)|ADXN: Company Future Sales Volume|ALZN: Company Projected Revenue|CYCN: Projected Sales Volume|Protagenic Therapeutics, Inc. (PTIX) - Projected Sales Volume|Company Projected Revenue Pasithea Therapeutics Corp|Company Revenue Forecast CRGT (Cortigent Medical)|Projected Sales Volume ATXI|BCLI - Company Expected Sales Volume|Cara Therapeutics - Company Future Sales Volume|Projected Sales Volume Chromocell Therapeutics Corp CHRO|ELYM - Company Projected Revenue|Company Future Revenue ITCI (Intra-Cellular Therapies)|Longboard Pharmaceuticals (LBPH) - Company Projected Revenue|Company Expected Sales Volume marinuspharma.com (MRNS)|Company Projected Revenue NKGen Biotech|Company Future Sales Volume NeuroBo Pharmaceuticals Inc (NRBO)|Projected Sales Volume SAGE|SNPX - Company Expected Sales Volume|Trevena, Inc. - Company Future Sales Volume|Company Projected Revenue Volume VIGL (Vigil Neuroscience Inc.)|Anew Medical, Inc. - Projected Sales Volume|CERE - Projected Sales Volume
